Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.

Ching THW, Stahnke B, Shnayder S, Agin-Liebes G, Adams TG Jr, Amoroso L, Baiz O, Belser A, Bohner C, Burke M, D'Amico E, DePalmer G, Eilbott J, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Purohit P, Schaer H, Sierra YP, Witherow C, Pittenger C, Kelmendi B

Open source

DOI: 10.3389/fpsyt.2025.1726818
Published: 2025
Container: Frontiers in psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2025.1726818,
  title = {Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.},
  author = {Ching THW and Stahnke B and Shnayder S and Agin-Liebes G and Adams TG Jr and Amoroso L and Baiz O and Belser A and Bohner C and Burke M and D'Amico E and DePalmer G and Eilbott J and Fram G and Grazioplene R and Hokanson J and Jankovsky A and Kichuk SA and Martins B and Purohit P and Schaer H and Sierra YP and Witherow C and Pittenger C and Kelmendi B},
  year = {2025},
  journal = {Frontiers in psychiatry},
  doi = {10.3389/fpsyt.2025.1726818},
  url = {https://doi.org/10.3389/fpsyt.2025.1726818}
}

RIS

TY  - JOUR
TI  - Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.
AU  - Ching THW
AU  - Stahnke B
AU  - Shnayder S
AU  - Agin-Liebes G
AU  - Adams TG Jr
AU  - Amoroso L
AU  - Baiz O
AU  - Belser A
AU  - Bohner C
AU  - Burke M
AU  - D'Amico E
AU  - DePalmer G
AU  - Eilbott J
AU  - Fram G
AU  - Grazioplene R
AU  - Hokanson J
AU  - Jankovsky A
AU  - Kichuk SA
AU  - Martins B
AU  - Purohit P
AU  - Schaer H
AU  - Sierra YP
AU  - Witherow C
AU  - Pittenger C
AU  - Kelmendi B
PY  - 2025
JO  - Frontiers in psychiatry
DO  - 10.3389/fpsyt.2025.1726818
UR  - https://doi.org/10.3389/fpsyt.2025.1726818
ER  -

APA

THW, C., B, S., S, S., G, A., Jr, A. T., L, A., O, B., A, B., C, B., M, B., E, D., G, D., J, E., G, F., R, G., J, H., A, J., SA, K., B, M., P, P., H, S., YP, S., C, W., C, P., & B, K. (2025). Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2025.1726818

Source records

pubmed · retrieved 2026-09-26T11:14:50.145Z